[Lupus nephropathy--therapeutic options 1996].
Matuszkiewicz-Rowińska
J
J
Kliniki Chorób Wewnetrznych, Akademii Medycznej w Warszawie.
Ostrowski
K
K
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D008181:Lupus Nephritis / Q000628:therapy*; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy; D011256:Pregnancy Outcome
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone
Nefropatia toczniowa--mozliwości terapeutyczne 1996.